METROPOLIS - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.2
| Stock Code | METROPOLIS | Market Cap | 9,460 Cr. | Current Price | 1,824 ₹ | High / Low | 2,263 ₹ |
| Stock P/E | 65.6 | Book Value | 256 ₹ | Dividend Yield | 0.05 % | ROCE | 13.4 % |
| ROE | 10.5 % | Face Value | 2.00 ₹ | DMA 50 | 1,884 ₹ | DMA 200 | 1,911 ₹ |
| Chg in FII Hold | -0.84 % | Chg in DII Hold | 1.63 % | PAT Qtr | 38.0 Cr. | PAT Prev Qtr | 46.6 Cr. |
| RSI | 43.7 | MACD | -19.9 | Volume | 52,620 | Avg Vol 1Wk | 83,590 |
| Low price | 1,315 ₹ | High price | 2,263 ₹ | PEG Ratio | -4.70 | Debt to equity | 0.11 |
| 52w Index | 53.7 % | Qtr Profit Var | 38.9 % | EPS | 26.6 ₹ | Industry PE | 36.9 |
📊 Metropolis Healthcare (METROPOLIS) shows decent fundamentals but weak technicals for swing trading. The RSI at 43.7 indicates neutral momentum, while the MACD (-19.9) reflects bearish sentiment. The stock is trading below both 50 DMA (1,884 ₹) and 200 DMA (1,911 ₹), showing short-term weakness. With a very high P/E of 65.6 compared to the industry average of 36.9, the stock appears overvalued. Overall, this is a moderately risky swing trade candidate with limited upside unless momentum improves.
💡 Optimal Entry Price: Around 1,800–1,830 ₹ (near support zone).
📈 Exit Strategy (if already holding): Consider exiting near 1,880–1,900 ₹ (close to 50 DMA resistance) unless momentum strengthens further.
✅ Positive
- Quarterly PAT stable (38 Cr. vs 46.6 Cr.).
- EPS of 26.6 ₹ reflects earnings consistency.
- ROCE (13.4%) and ROE (10.5%) are modest but positive.
- DII holdings increased (+1.63%), showing strong domestic investor support.
- Debt-to-equity ratio of 0.11 indicates low leverage.
⚠️ Limitation
- Stock trading below both 50 DMA and 200 DMA.
- Bearish technical indicators (MACD negative, RSI weak).
- High P/E (65.6) compared to industry average (36.9).
- PEG ratio of -4.70 suggests poor valuation relative to growth.
- Dividend yield is very low (0.05%).
📉 Company Negative News
- FII holdings decreased (-0.84%), showing reduced foreign investor confidence.
- Stock has dropped from 52-week high (2,263 ₹ to 1,824 ₹).
📈 Company Positive News
- DII holdings increased significantly (+1.63%), showing strong domestic support.
- Quarterly profit variation (38.9%) shows resilience despite sector challenges.
- Stock trading near support levels, offering rebound potential.
🏭 Industry
- Industry PE is 36.9, much lower than Metropolis’ 65.6, suggesting peers are more reasonably valued.
- Diagnostics and healthcare sector remains defensive with consistent demand but faces pricing and competition pressures.
🔎 Conclusion
Metropolis Healthcare is a moderately risky swing trade candidate due to bearish technicals and high valuation. Entry near 1,800–1,830 ₹ offers limited risk, but upside is capped around 1,880–1,900 ₹ unless momentum improves. Strong domestic investor support and stable earnings provide some confidence, but weak technicals and declining foreign interest make this suitable only for cautious short-term trades.